Analysis of the Consumption of Drugs Prescribed for the Treatment of Asthma in Belgian Children

International Journal of Environmental Research and Public Health

Carine De Vriese¹  Natacha Biset¹  Stéphanie Pochet¹  Dominique Detemmerman²  Ann Ceuppens²  Murielle Lona²  Güngör Karakaya²  Wies Kestens² 

[1] Department of Pharmacotherapy and Pharmaceutics, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium;Department of Studies & Innovation, Mutualités Libres—Onafhankelijke Ziekenfondsen, 1070 Brussels, Belgium;

关键词: children;    respiratory disease;    asthma;    treatment;   

DOI  :  10.3390/ijerph19010548

来源: DOAJ

【 摘 要 】

(1) Asthma is one of the most common chronic diseases in the world among children. The main purpose of this study was to analyze the consumption of asthma medications in order to investigate asthma in children (2–18 years) and the association with health care consumption; (2) a retrospective study using anonymized administrative data for 2013–2018 from the third largest Belgian health insurer was conducted; (3) in 2018, 12.9% of children received at least one asthma medication and 4.4% received at least two packages with a minimum of 30 days between purchases. Preschool children (2–6 years) were three times more likely to take asthma medication than older children (7–18 years). ICS, in combination or not with LABA, were the most dispensed drugs among children. Children with asthma medications were almost twice as likely to receive antibiotics, more likely to end up in the emergency room, and twice as likely to be hospitalized; (4) most children took ICS, according to the GINA guidelines. High rates of nebulization in young children were observed, despite the recommendation to use an inhaler with a spacing chamber as much as possible. Finally, children who took asthma medications were more likely to end up in the ER or be hospitalized.

【 授权许可】

Unknown